In-solution and on-plate light-catalyzed E/Z isomerization of cyclic chalcone analogues. Lipophilicity of E- and Z-2-(X-benzylidene)-1-benzosuberones.

Some cyclic chalcone analogues [E-2-(X-benzylidene)-1-indanones, -tetralones, and -benzosuberones], on-plate UV light-catalyzed formation of new chromatographic spots, can be observed during thin-layer chromatography (TLC). Gas chromatographic (GC) analysis of selected derivatives indicates the formation of one new substance in each case. GC coupled with mass spectrometry and 1H NMR analysis of the samples reveals that the compounds formed are the respective Z-2-(X-benzylidene)-1-indanones, -tetralones, and -benzosuberones. Two-dimensional TLC shows that the E/Z isomerization is a reversible process. By means of the RP-TLC, the logarithm of n-octanol-water partition coefficient (log P) values of E- and Z-isomeric pairs of selected 2-(X-benzylidene)-1-benzosuberones is determined. The Z-isomers are less lipophilic than the E-isomers.

[1]  K. Wanner,et al.  Methods and Principles in Medicinal Chemistry , 2007 .

[2]  J. Linnanto,et al.  E-2-Benzylidenebenzocycloalkanones. IV. Studies on transmission of substituent effects on 13C NMR chemical shifts of E-2-(X-benzylidene)-1-tetralones, and -benzosuberones. Comparison with the 13C NMR data of chalcones and E-2-(X-benzylidene)-1-indanones , 2005 .

[3]  I Kövesdi,et al.  Reliability of logP predictions based on calculated molecular descriptors: a critical review. , 2002, Current medicinal chemistry.

[4]  E. De Clercq,et al.  Correlations between cytotoxicity and topography of some 2-arylidenebenzocycloalkanones determined by X-ray crystallography. , 2002, Journal of medicinal chemistry.

[5]  K. Vékey,et al.  E-2-benzylidenebenzocyclanones. II. IR and mass spectrometric investigations , 2000 .

[6]  J. Dimmock,et al.  Bioactivities of chalcones. , 1999, Current medicinal chemistry.

[7]  L. Prasad,et al.  Conformational and quantitative structure-activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones. , 1999, Journal of medicinal chemistry.

[8]  György Tarczay,et al.  E-2-Benzylidenebenzocycloalkanones. Stereostructure and NMR spectroscopic investigation , 1999 .

[9]  J. Kökösi,et al.  Characterization of potential NMDA and cholecystokinin antagonists. II. Lipophilicity studies on 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acid derivatives. , 1999, International journal of pharmaceutics.

[10]  D. Schuster.  The photochemistry of enones , 1990 .

[11]  A. Guarna,et al.  Gas chromatographic analysis of trans- and cis-dypnone , 1974 .

[12]  E. D. Weiler,et al.  cis-trans Isomerism of Exocyclic α,β-Unsaturated Indanones and Tetralones , 1964 .

[13]  H. Otto,et al.  Spektroskopische und chromatographische Untersuchungen zur photochemischen Isomerisierung von α, ss-diungesättigten Ketonen , 2003 .

[14]  P. Perjési,et al.  Determination of logP for biologically active chalcones and cyclic chalcone analogs by RPTLC , 2001 .

[15]  M. Meegan,et al.  Benzylideneindanones and Benzylidenebenzosuberones: Relationship between Structure, Antimycotic Activity and Acute Toxicity , 1997 .

[16]  P. Baas.  Conformational study on some -phenyl-a,-unsaturated ketones , 1977 .

[17]  E. D. Weiler,et al.  Nuclear magnetic resonance spectra of derivatives of various substituted indanones and tetralones , 1967 .